Grants4Targets: an open innovation initiative to foster drug discovery collaborations.

The article discusses the Grants4Targets (G4T), a crowdsourcing initiative, that had been launched by Bayer Healthcare AG. It aims to combine expertise from academic researchers and researchers in the pharmaceutical industry to identify and validate novel drug targets and biomarkers. An update on the firm's experiences with the programme, results generated and successes achieved, and feedback from both the grant receivers and in-house scientists acting as reviewers and caretakers is provided.